Together with Erasmus University, we provide unique executive programs and counseling for Health-Tech and Med-Tech start-ups.

We are a science- and quality-focused company with the goal of providing innovative Point of Care and In Vitro Diagnostics technology to medical and health care professionals.

The POC testing market is set to reach $49 billion by 2020 and is growing in all major segments: hospitals, ambulatory care settings, physician offices and home care.
Our Clinical study division is a platform for various (university) clinical chemistry laboratories in the Netherlands, Germany and Belgium.
Together with Erasmus University, we provide unique executive programs and counseling for Health-Tech and Med-Tech start-ups.
We are a science- and quality-focused company with the goal of providing innovative Point of Care and In Vitro Diagnostics technology to medical and health care professionals.
The POC testing market is set to reach $49 billion by 2020 and is growing in all major segments: hospitals, ambulatory care settings, physician offices and home care.
Our Clinical study division is a platform for various (university) clinical chemistry laboratories in the Netherlands, Germany and Belgium.
Our POC & IVD division is specialized in valorization, developing high-quality innovative medical technologies and cooperates with several international medical technology companies for introducing innovative medical tests to the market. Our team members and our partners are devoted researchers and scientists with an impressive track record, and they address upcoming clinical and economic needs through applied research and innovative technology.

Office Europe:
Life Science Business
Flight Forum 40
5657 DB Eindhoven
The Netherlands

Contact information:
E: info@lifesciencebusiness.nl

Tel.: 0031-(0)40 - 7983021

Office The Middle East :
Life Science Business
P. O. Box: 122022
Sharjah
The UAE